Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, $0.0001 par value
-
Shares outstanding
-
172,779,139
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
42,586,066
-
Shares change
-
+9,722,259
-
Total reported value, excl. options
-
$1,736,374,072
-
Value change
-
+$365,354,803
-
Put/Call ratio
-
15%
-
Number of buys
-
83
-
Number of sells
-
-40
-
Price
-
$40.76
Significant Holders of Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) as of Q4 2023
153 filings reported holding GPCR - Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value as of Q4 2023.
Structure Therapeutics Inc. - Ordinary Shares, $0.0001 par value (GPCR) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42,586,066 shares
of 172,779,139 outstanding shares and own 25% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4,372,326 shares), FMR LLC (4,034,584 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (2,599,079 shares), Avoro Capital Advisors LLC (2,333,333 shares), FEDERATED HERMES, INC. (2,267,206 shares), TCG Crossover Management, LLC (2,109,584 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,756,918 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,679,436 shares), JANUS HENDERSON GROUP PLC (1,544,416 shares), and T. Rowe Price Investment Management, Inc. (1,312,195 shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.